The safety and effectiveness of prophylactic hyperthermic intraperitoneal chemotherapy in patients with pathological T3-4 locally advanced colon cancer
CONCLUSION: Early prophylactic HIPEC based on 5-FU or lobaplatin subsequent to radical resection for patients with pT3-4 locally advanced CC is safe, but not effective in reducing the risk for mPC.PMID:38604861 | DOI:10.1016/j.asjsur.2024.03.143
Source: Asian Journal of Surgery - Category: Surgery Authors: Taiwei Mo Xiaofeng Wen Tuo Hu Zongjin Zhang Yaqian Shi Yongle Chen Haidong Xiang Junhua Huang Zhenyu Xian Xiaowen He Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Colon Cancer | Colorectal Cancer | Peritoneal Cancer | Study | Surgery